Commerzbank Aktiengesellschaft’s AbbVie ABBV Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-11,000	Closed	-$51K	–	103
2020 Q1	$51K	Buy	+11,000	New	+$937K	﹤0.01%	435
2019 Q3	–	Sell	-131,700	Closed	-$2.79M	–	834
2019 Q2	$2.79M	Buy	+131,700	New	+$10.4M	0.02%	396
2019 Q1	–	Sell	-12,300	Closed	-$28K	–	863
2018 Q4	$28K	Hold	12,300	–	–	﹤0.01%	928
2018 Q3	$43K	Buy	+12,300	New	+$1.17M	﹤0.01%	957

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Commerzbank Aktiengesellschaft's ABBV Position: Q1 2026 in Review

Commerzbank Aktiengesellschaft reduced its AbbVie (ABBV) stake by 9.3% in Q1 2026, selling an estimated $1.63M and leaving 72,061 shares worth $15.7M. The position accounts for 0.33% of the portfolio, ranked #45.

Commerzbank Aktiengesellschaft first reported a position in ABBV in Q2 2013 and has held it in 40 quarters since. The position peaked at $62.6M in Q2 2013. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Commerzbank Aktiengesellschaft held 72,061 shares of AbbVie worth $15.7M as of Q1 2026.
Commerzbank Aktiengesellschaft sold 7,351 AbbVie shares in Q1 2026, an estimated $1.63M.
AbbVie made up 0.33% of Commerzbank Aktiengesellschaft's portfolio in Q1 2026, its #45 holding.
Commerzbank Aktiengesellschaft first reported a position in AbbVie in Q2 2013 and has held it in 40 quarters since.
Commerzbank Aktiengesellschaft's AbbVie position peaked at $62.6M in Q2 2013.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2026, filed 7 May 2026.